Now showing 1 - 10 of 23
  • 2020Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","394"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Translational Medicine"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Bahls, Thomas"],["dc.contributor.author","Pung, Johannes"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hauswaldt, Johannes"],["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","Blumentritt, Arne"],["dc.contributor.author","Rau, Henriette"],["dc.contributor.author","Drepper, Johannes"],["dc.contributor.author","Wieder, Philipp"],["dc.contributor.author","Groh, Roland"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Schlegelmilch, Falk"],["dc.date.accessioned","2020-10-29T15:25:39Z"],["dc.date.available","2020-10-29T15:25:39Z"],["dc.date.issued","2020"],["dc.description.abstract","Medical data from family doctors are of great importance to health care researchers but seem to be locked in German practices and, thus, are underused in research. The RADAR project (Routine Anonymized Data for Advanced Health Services Research) aims at designing, implementing and piloting a generic research architecture, technical software solutions as well as procedures and workflows to unlock data from family doctor's practices. A long-term medical data repository for research taking legal requirements into account is established. Thereby, RADAR helps closing the gap between the European countries and to contribute data from primary care in Germany."],["dc.identifier.doi","10.1186/s12967-020-02547-x"],["dc.identifier.pmid","33076938"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/17623"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68099"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation","RADARplus - Anonymisierte Routinedaten aus der ambulanten Versorgung für die Versorgungsforschung"],["dc.relation.issn","1479-5876"],["dc.relation.orgunit","Institut für Medizinische Informatik"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Designing and piloting a generic research architecture and workflows to unlock German primary care data for secondary use"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2017-12Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","905"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","International Journal of Clinical Pharmacology and Therapeutics"],["dc.bibliographiccitation.lastpage","910"],["dc.bibliographiccitation.volume","55"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2021-08-26T14:46:04Z"],["dc.date.available","2021-08-26T14:46:04Z"],["dc.date.issued","2017-12"],["dc.description.abstract","A chart review at a mid-sized German general hospital found a high usage of benzodiazepines among older patients. Therefore, all doctors and nurses of this hospital were surveyed about the benefits and risks of benzodiazepines that they considered to be the strongest and their own overall assessment of the risk-benefit ratio for their patients Response rate was 54% (63/116) for doctors and 30% (73/243) for nurses. \"Reduced fear or agitation\" was perceived by many doctors (71%) and nurses (49%) to be a strong benefit of benzodiazepines. With regards to the overall risk-benefit ratio, doctors who indicated that \"falls\" and/or \"craving\" often occur in combination with benzodiazepines were more likely to estimate that the risks of benzodiazepines outweigh the benefits. For nurses, \"confusion\" strongly influenced their overall assessment of the risk-benefit ratio. The results of this study will be incorporated into interventions for reducing benzodiazepine prescriptions.
."],["dc.identifier.doi","10.5414/CP203104"],["dc.identifier.pmid","29092732"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88877"],["dc.language.iso","en"],["dc.relation.issn","0946-1965"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Searching for factors that may reduce the use of benzodiazepines in hospitals - a survey of hospital doctors and nurses
"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2019Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","285"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","European Journal of Clinical Pharmacology"],["dc.bibliographiccitation.lastpage","290"],["dc.bibliographiccitation.volume","76"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Brockmöller, Jürgen"],["dc.contributor.author","Hagmayer, York"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2020-12-10T14:09:57Z"],["dc.date.available","2020-12-10T14:09:57Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1007/s00228-019-02783-1"],["dc.identifier.eissn","1432-1041"],["dc.identifier.issn","0031-6970"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70614"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","Why Z-drugs are used even if doctors and nurses feel unable to judge their benefits and risks—a hospital survey"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2019Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","1014"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Pharmacoepidemiology and Drug Safety"],["dc.bibliographiccitation.lastpage","1022"],["dc.bibliographiccitation.volume","28"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Neukirchen, Freya"],["dc.contributor.author","Nau, Roland"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2021-08-26T11:02:39Z"],["dc.date.available","2021-08-26T11:02:39Z"],["dc.date.issued","2019"],["dc.description.abstract","To find out whether any prior experiences with sleep-inducing drugs before hospitalization and positive experiences with these drugs during hospitalization influence a patient's wish to continue taking sleep-inducing drugs after hospitalization."],["dc.identifier.doi","10.1002/pds.4806"],["dc.identifier.pmid","31179613"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16729"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88811"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation","Schlaf- und Beruhigungsmittel an der Schnittstelle von Krankenhaus und Hausarzt"],["dc.relation.eissn","1099-1557"],["dc.relation.issn","1053-8569"],["dc.relation.issn","1099-1557"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Patient-reported factors associated with the desire to continue taking sleep-inducing drugs after hospital discharge: A survey of older adults"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2019-12Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","22"],["dc.bibliographiccitation.journal","Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen"],["dc.bibliographiccitation.lastpage","31"],["dc.bibliographiccitation.volume","149"],["dc.contributor.author","Hauswaldt, Johannes"],["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Pung, Johannes"],["dc.contributor.author","Schlegelmilch, Falk"],["dc.contributor.author","Drepper, Johannes"],["dc.date.accessioned","2020-10-29T15:25:48Z"],["dc.date.available","2020-10-29T15:25:48Z"],["dc.date.issued","2019-12"],["dc.description.abstract","The use of primary care data gathered from electronic health records in local practices could be an important building block for the future of health services research. However, the risks and reservations associated with using this data for research purposes should not be underestimated. We show the data protection and privacy problems that may arise through secondary analysis of routine primary care data and describe the technical solutions that are available to address these concerns - as a trust-building measure."],["dc.identifier.doi","10.1016/j.zefq.2020.01.002"],["dc.identifier.pmid","32165110"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68101"],["dc.language.iso","other"],["dc.relation","RADARplus - Anonymisierte Routinedaten aus der ambulanten Versorgung für die Versorgungsforschung"],["dc.relation.eissn","2212-0289"],["dc.relation.issn","1865-9217"],["dc.relation.orgunit","Institut für Medizinische Informatik"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY-NC-ND 4.0"],["dc.title","Das Risiko von Re-Identifizierung bei der Auswertung medizinischer Routinedaten – Kritische Bewertung und Lösungsansätze"],["dc.title.alternative","The risk of re-identification when analyzing electronic health records: a critical appraisal and possible solutions"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2022Journal Article Research Paper
    [["dc.bibliographiccitation.journal","Frontiers in Public Health"],["dc.bibliographiccitation.volume","10"],["dc.contributor.affiliation","Schröder, Dominik; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heesen, Gloria; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heinemann, Stephanie; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Hummers, Eva; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Jablonka, Alexandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Steffens, Sandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Mikuteit, Marie; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Niewolik, Jacqueline; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Overbeck, Tobias R.; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Kallusky, Jonathan; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Müller, Frank; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Kallusky, Jonathan"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Overbeck, Tobias R."],["dc.date.accessioned","2022-04-26T12:34:44Z"],["dc.date.available","2022-04-26T12:34:44Z"],["dc.date.issued","2022"],["dc.date.updated","2022-05-10T16:09:22Z"],["dc.description.abstract","Background: Restrictions to contain the COVID-19 pandemic affect the social participation of people worldwide. Especially those at high risk for a severe disease tend to abstain from social gatherings. While there are a few questionnaires to measure social participation in elderly or chronic patients, a valid survey instrument that includes pandemic-related social participation is needed. Methods We developed a social participation questionnaire that aims to assess pandemic-related restrictions in social participation. Items were developed using a theory and literature-based approach and then compiled in a discursive process involving experts and lay people. This was followed by the validation of the questionnaire through a cross-sectional survey on 431 individuals. Items with low item-total correlations and low factor loadings using exploratory factor analysis [EFA] were excluded. Using EFA on the remaining items, the factor structure was retrieved and tested with a confirmatory factor analysis [CFA]. Internal consistency was assessed with Chronbachs α. Results Initially, 27 items were developed which were used for validation. 13 items were excluded due to low item-total correlations and factors loadings. EFA of the remaining 14 items revealed three factors which were identified as domains “active social participation,” “wellbeing,” and “restrictions”. CFA showed an acceptable model fit using the three-dimensional structure. Chronbachs α of 0.81 and McDonalds Ω of 0.87 indicate good internal consistency. Correlation analysis showed an association between the developed questionnaire and previously-established participation and mental health scales. Conclusion This study suggests that our 14 item questionnaire is of high reliability and validity and can be used to measure social participation during a pandemic."],["dc.identifier.doi","10.3389/fpubh.2022.831087"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106769"],["dc.language.iso","en"],["dc.publisher","Frontiers Media S.A."],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.issn","2296-2565"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights.uri","http://creativecommons.org/licenses/by/4.0/"],["dc.title","Development and Validation of a Questionnaire to Assess Social Participation of High Risk-Adults in Germany During the COVID-19 Pandemic"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2022Monograph Text Edition
    [["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","El-Sayed, Iman"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Königs, Gloria"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Müllenmeister, Christina"],["dc.contributor.author","Nußbaum, Kathrin"],["dc.contributor.author","Schmachtenberg, Tim"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.editor","Roder, Sascha"],["dc.contributor.editorcorporation","Sascha Roder"],["dc.date.accessioned","2022-11-07T10:03:36Z"],["dc.date.available","2022-11-07T10:03:36Z"],["dc.date.issued","2022"],["dc.identifier.isbn","978-3-00-073127-3"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/116942"],["dc.language.iso","de"],["dc.publisher","Universitätsmedizin Göttingen"],["dc.publisher.place","Göttingen"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","(Er-)Leben mit Long COVID"],["dc.title.subtitle","Projektergebnisse einer qualitativen Studie bildhaft interpretiert"],["dc.type","book"],["dc.type.internalPublication","yes"],["dc.type.subtype","collection_book"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details
  • 2017-12-04Journal Article Research Paper
    [["dc.bibliographiccitation.artnumber","76"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","BMC Pharmacology & Toxicology"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Arnold, Inken"],["dc.contributor.author","Straube, Kati"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Weiß, Vivien"],["dc.contributor.author","Heyden, Laura Miriam"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Nau, Roland"],["dc.date.accessioned","2018-04-18T14:43:20Z"],["dc.date.accessioned","2021-10-27T13:21:05Z"],["dc.date.available","2018-04-18T14:43:20Z"],["dc.date.available","2021-10-27T13:21:05Z"],["dc.date.issued","2017-12-04"],["dc.date.updated","2018-04-18T14:43:20Z"],["dc.description.abstract","Background Many elderly patients receive psychotropic drugs. Treatment with psychotropic agents is associated with serious side effects including an increased risk of falls and fractures. Several psychotropic drugs are considered potentially inappropriate for treatment of the elderly. Methods A retrospective chart review was conducted covering all patients aged ≥ 65 years who were admitted to Evangelisches Krankenhaus Göttingen-Weende between 01/01/2013 and 03/31/2013. Psychotropic drugs reviewed for included benzodiazepines, Z-drugs, antidepressants and neuroleptics, but not drugs for sedation during artificial ventilation or pre-medication before surgery. Potentially inappropriate drugs were identified according to the PRISCUS list. To assess which factors were associated with the administration of psychotropic drugs, univariate and multivariable logistic regression analyses were performed. Results The charts of 2130 patients (1231 women) were analyzed. 53.9% of all patients received at least one psychotropic medication (29.5% benzodiazepines, 12.6% Z-drugs, 22.2% antidepressants, 11.9% neuroleptics). The mean number of psychotropic drugs prescribed per patient with at least one prescription was 1.6. Patients treated in the geriatric department most often received antidepressants (45.0%), neuroleptics (20.6%) and Z-drugs (27.5%). Benzodiazepines and Z-drugs were prescribed mostly as medication on demand (77.7% of benzodiazepines, 73.9% of Z-drugs). Surgical patients most frequently received benzodiazepines (37.1%). Nearly one-third of all patients ≥ 65 years was treated with at least one potentially inappropriate psychotropic medication. The mean number of potentially inappropriate psychotropic medications per patient with at least one psychotropic prescription was 0.69. The percentage of patients with potentially inappropriate psychotropic medication was highest in the surgical departments (74.1%). Female gender (adjusted OR 1.36; 95% CI 1.14 to 1.63), stay in the Department of Geriatrics (2.69; 2.01 to 3.60) or the interdisciplinary intensive care unit (1.87; 1.33 to 2.64) and age ≥ 85 years (1.33; 1.10 to 1.60) were associated with psychotropic drug treatment. Conclusions A high percentage of patients aged ≥ 65 years received psychotropic drugs. The chance that a potentially inappropriate psychotropic drug would be administered was highest in the surgical departments. Antidepressants, neuroleptics and Z-drugs were used surprisingly often in geriatric medicine. Educational strategies could reduce the use of psychotropic drugs and the prescription of potentially inappropriate medications."],["dc.identifier.doi","10.1186/s40360-017-0183-0"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/15171"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/91993"],["dc.language.rfc3066","en"],["dc.notes.intern","Migrated from goescholar"],["dc.relation.euproject","The study was funded by the German Federal Ministry of Health, the research grant was awarded in a competitive, peer-reviewed procedure (grant number: FKZ-IIA5-2513DSM228)"],["dc.relation.orgunit","Universitätsmedizin Göttingen"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.holder","The Author(s)."],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","High prevalence of prescription of psychotropic drugs for older patients in a general hospital"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2022Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","Zeitschrift für Rheumatologie"],["dc.bibliographiccitation.lastpage","11"],["dc.bibliographiccitation.volume","May 6"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Noack, Eva Maria"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Dopfer-Jablonka, Alexandra"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Schröder, Dominik"],["dc.creator.author","Frank Müller"],["dc.creator.author","Stephanie Heinemann"],["dc.creator.author","Eva Hummers"],["dc.creator.author","Eva Maria Noack"],["dc.creator.author","Gloria Heesen"],["dc.creator.author","Alexandra Dopfer-Jablonka"],["dc.creator.author","Marie Mikuteit"],["dc.creator.author","Jacqueline Niewolik"],["dc.creator.author","Sandra Steffens"],["dc.creator.author","Dominik Schröder"],["dc.date.accessioned","2022-05-07T01:54:33Z"],["dc.date.available","2022-05-07T01:54:33Z"],["dc.date.issued","2022"],["dc.description.abstract","Immunocompromised people are less likely to be vaccinated, despite an increased benefit of many vaccinations in terms of benefit-risk assessment, including the vaccines against SARS CoV-2 (COVID-19). Attitudes, expectations, and experiences with previous vaccinations influence the decision to get vaccinated."],["dc.identifier.doi","10.1007/s00393-022-01213-5"],["dc.identifier.pmid","35523964"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/108140"],["dc.identifier.url","https://publications.goettingen-research-online.de/handle/2/107676"],["dc.language.iso","de"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.eissn","1435-1250"],["dc.relation.issn","0340-1855"],["dc.relation.issn","1435-1250"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.subject.gro","Immunosuppression; SARS-CoV‑2; Vaccination; Vaccination acceptance; Vaccine Uptake; Vaccine hesitancy"],["dc.title","Impfeinstellung, Erwartungen und Impferfahrung von Immunsupprimierten bei COVID-19 Impfungen - Ergebnisse einer Längsschnittstudie"],["dc.title.alternative","Immunosuppressed people's beliefs, expectations, and experiences with COVID-19 vaccinations: Results of a longitudinal study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC
  • 2019Journal Article Research Paper
    [["dc.bibliographiccitation.artnumber","e104"],["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","Primary Health Care Research and Development"],["dc.bibliographiccitation.lastpage","9"],["dc.bibliographiccitation.volume","20"],["dc.contributor.author","Schäfer, Willemijn L.A."],["dc.contributor.author","Boerma, Wienke G.W."],["dc.contributor.author","van den Berg, Michael J."],["dc.contributor.author","De Maeseneer, Jan"],["dc.contributor.author","De Rosis, Sabina"],["dc.contributor.author","Detollenaere, Jens"],["dc.contributor.author","Greß, Stefan"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","van Loenen, Tessa"],["dc.contributor.author","Murante, Anna Maria"],["dc.contributor.author","Pavlič, Danica R."],["dc.contributor.author","Seghieri, Chiara"],["dc.contributor.author","Vainieri, Milena"],["dc.contributor.author","Willems, Sara"],["dc.contributor.author","Groenewegen, Peter P."],["dc.date.accessioned","2020-12-10T15:22:23Z"],["dc.date.available","2020-12-10T15:22:23Z"],["dc.date.issued","2019"],["dc.description.abstract","Aim: This article synthesises the results of a large international study on primary care (PC), the QUALICOPC study. Background: Since the Alma Ata Declaration, strengthening PC has been high on the policy agenda. PC is associated with positive health outcomes, but it is unclear how care processes and structures relate to patient experiences. Methods: Survey data were collected during 2011–2013 from approximately 7000 PC physicians and 70 000 patients in 34, mainly European, countries. The data on the patients are linked to data on the PC physicians within each country and analysed using multilevel modelling. Findings: Patients had more positive experiences when their PC physician provided a broader range of services. However, a broader range of services is also associated with higher rates of hospitalisations for uncontrolled diabetes, but rates of avoidable diabetes-related hospitalisations were lower in countries where patients had a continuous relationship with PC physicians. Additionally, patients with a long-term relationshipwith their PC physicianwere less likely to attend the emergency department. Capitation payment was associated with more positive patient experiences. Mono- and multidisciplinary co-location was related to improved processes in PC, but the experiences of patients visiting multidisciplinary practices were less positive. A stronger national PC structure and higher overall health care expenditures are related to more favourable patient experiences for continuity and comprehensiveness. The study also revealed inequities: patients with a migration background reported less positive experiences. People with lower incomes more often postponed PC visits for financial reasons. Comprehensive and accessible care processes are related to less postponement of care. Conclusions: The study revealed room for improvement related to patient-reported experiences and highlighted the importance of core PC characteristics including a continuous doctor–patient relationship as well as a broad range of services offered by PC physicians."],["dc.identifier.doi","10.1017/S1463423619000434"],["dc.identifier.eissn","1477-1128"],["dc.identifier.issn","1463-4236"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16288"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/73381"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.notes.intern","Merged from goescholar"],["dc.relation.issn","1463-4236"],["dc.relation.issn","1477-1128"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Are people’s health care needs better met when primary care is strong? A synthesis of the results of the QUALICOPC study in 34 countries"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]
    Details DOI